Cabaletta Bio (CABA) announced new and updated clinical data on CABA-201 demonstrating the potential to achieve drug-free, compelling clinical ...
The presentation entitled, " Safety and Efficacy Data from a Phase I Trial of Umbilical Lining Stem Cells (ULSCs) in Adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback